MREO vs AMGN: Which Stock is Better?
Side-by-side comparison of Mereo Biopharma Group Plc and Amgen Inc in 2026
MREO
Mereo Biopharma Group Plc
$0.39
AMGN
Amgen Inc
$369.53
Key Metrics Comparison
| Metric | MREO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $62.71M | $199.20B | AMGN |
| P/E Ratio | N/A | 25.84 | AMGN |
| EPS (TTM) | $N/A | $14.30 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 73.4% | 70.8% | MREO |
Analyze MREO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or AMGN a better investment?
Comparing MREO and AMGN: Mereo Biopharma Group Plc has a market cap of $62.71M while Amgen Inc has $199.20B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and AMGN?
MREO (Mereo Biopharma Group Plc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for MREO.
Which company is more profitable: MREO or AMGN?
Mereo Biopharma Group Plc (MREO) has higher gross margins at 73.4% compared to 70.8% for AMGN.
Which is the larger company: MREO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $199.20B compared to $62.71M for MREO.
Should I buy MREO or AMGN in 2026?
Both MREO and AMGN have investment merit. MREO trades at $0.39 while AMGN trades at $369.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and AMGN stock?
Key differences: Market Cap ($62.71M vs $199.20B), P/E Ratio (N/A vs 25.8x), Revenue Growth (0.0% vs 0.1%), Gross Margin (73.4% vs 70.8%).